1 Market Definitions & Methodology
2 Executive Summary
3 Indian Antibodies Market
4 Antibody Based Diagnostics Market in India
4.1 Industry Analysis
4.1.1 Strengths
4.1.2 Weaknesses
4.1.3 Opportunities
4.1.4 Threats
4.2 Technological & Regulatory Assessment
4.2.1 Technological Assessment
4.2.2 Regulatory Assessment
4.3 Market Analysis
4.3.1 Current & Future Sales Trends
4.3.2 Market Segments by Usage
4.3.2.1 HIV Diagnostics: Current Trends & Forecast
4.3.2.2 Hepatitis B Diagnostics: Current Trends & Forecast
4.3.2.3 Hepatitis C Diagnostics: Current Trends & Forecast
4.3.2.4 Tuberculosis Diagnostics: Current Trends & Forecast
4.3.2.5 Dengue Diagnostics: Current Trends & Forecast
4.3.2.6 Pregnancy Diagnostics: Current Trends & Forecast
4.3.2.7 Syphilis Diagnostics: Current Trends & Forecast
4.3.2.8 Oncology Diagnostics: Current Trends & Forecast
5 Therapeutic Antibodies Market in India
5.1 Industry Analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2 Technological & Regulatory Assessment
5.2.1 Technological Assessment
5.2.2 Regulatory Assessment
5.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India
5.4 Market Analysis
5.4.1 Current & Future Sales Trends
5.4.2 Sales Breakup by Molecule
5.4.3 Sales by Indication
5.5 Evaluation of Top Monoclonal Antibodies
5.5.1.1 Avastin
5.5.1.2 Herceptin
5.5.1.3 Rituxan/Mabthera
5.5.1.4 Remicade
5.5.1.5 Humira
5.6 Biosimilar Case Studies
5.6.1 Reditux
5.6.2 Grafeel
5.7 Key Indian & Foreign Biosimilar Antibody Development Programmes
List of Figures
Figure 3 1: India - Antibodies Market Forecast, 2024-2032
Figure 3 2: India - Antibodies Market Forecast - Breakup by Segment (in %), 2024-2032
Figure 4 1: India - Overview of Elisa and Rapid Tests
Figure 4 2: India - In-Vitro Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 3: India - Immunodiagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 4: India - Immunodiagnostics Market Forecast: Breakup by Indication (in %), 2024 & 2032
Figure 4 5: India - HIV Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 6: India - HIV Diagnostics Market: Volume Share by Lab (in %), 2023
Figure 4 7: India - HIV Diagnostics Market: Value & Volume Share of Various Tests (in %), 2023
Figure 4 8: India - Hepatitis B Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 9: India - Hepatitis B Diagnostics Market: Share of Various Tests (in %), 2023
Figure 4 10: India - Hepatitis C Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 11: India - Hepatitis C Diagnostics Market: Share of Various Tests (in %), 2023
Figure 4 12: India - Tuberculosis Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 13: India - Tuberculosis Diagnostics Market: Share of Various Tests (in %), 2023
Figure 4 14: India - Dengue Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 15: India - Dengue Diagnostics Market: Volume Share of Various Tests (in %), 2023
Figure 4 16: India - Pregnancy Market Forecast (in INR Million), 2024-2032
Figure 4 17: India - Syphilis Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 4 18: India - Syphilis Diagnostics Market: Volume Share of Various Tests (in %), 2023
Figure 4 19: India - Cancer Diagnostics Market Forecast (in INR Million), 2024-2032
Figure 5 1: Monoclonal Antibodies Based on Their Sources
Figure 5 2: India - Approval Process for a New Drug
Figure 5 3: Global - Monoclonal Antibodies Market Forecast (in INR Million), 2024-2032
Figure 5 4: India - Monoclonal Antibodies Market Forecast (in INR Million), 2024-2032
Figure 5 5: Global - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2023
Figure 5 6: India - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2023
Figure 5 7: Global - Monoclonal Antibodies Market by Indication (in %), 2023
Figure 5 8: India - Monoclonal Antibodies Market by Indication (in %), 2024-2032
Figure 5 9: Global - Avastin Sales (in INR Million), 2018-2023
Figure 5 10: Global - Avastin Sales Forecast (in INR Million), 2024-2032
Figure 5 11: Global - Herceptin Sales (in INR Million), 2018-2023
Figure 5 12: Global - Herceptin Sales Forecast (in INR Million), 2024-2032
Figure 5 13: Global - Rituxan/Mabthera Sales (in INR Million), 2018-2023
Figure 5 14: Global - Rituxan/Mabthera Sales Forecast (in INR Million), 2024-2032
Figure 5 15: Global - Remicade Sales (in INR Million), 2018-2023
Figure 5 16: Global - Remicade Sales Forecast (in INR Million), 2024-2032
Figure 5 17: Global - Humira Sales (in INR Million), 2018-2023
Figure 5 18: Global - Humira Sales Forecast (in INR Million), 2024-2032
Figure 5 19: India - Reditux Sales (in INR Million), 2018-2022
Figure 5 20: India - Impact of Grafeel on G-CSF Market Size & Prices, 2018-2022
List of Tables
Table 1 1: Monoclonal Antibodies Market: Market Definitions
Table 1 2: India - Immunodiagnostics Market: Market Definitions
Table 2 1: India - Diagnostic Antibodies Market - SWOT Analysis
Table 2 2: India - Executive Summary - Immunodiagnostics Market: Overview of Various Indications, 2023
Table 2 3: India - Therapeutic Antibodies Market - SWOT Analysis
Table 4 1: India - Statistics of Various Indications
Table 4 2: India - Comparison of Rapid & Elisa Tests
Table 4 3: India - Immunodiagnostics Market: Overview of Various Indications, 2023
Table 4 4: India - HIV Diagnostics Market: Key Statistics, 2023
Table 4 5: India - Hepatitis B Diagnostics Market: Key Statistics, 2023
Table 4 6: India - Hepatitis C Diagnostics Market: Key Statistics, 2023
Table 4 7: India - Tuberculosis Diagnostics Market: Key Statistics, 2023
Table 4 8: India - Cancer Diagnostics Market: Overview of Various Cancer Markers
Table 5 1: Globally Launched Monoclonal Antibodies & Their Targets
Table 5 2: US, Europe & India - Patent Details of Various Monoclonal Antibodies
Table 5 3: Global & Indian: Monoclonal Antibodies Market - Statistics of Various Brands
Table 5 4: India - Monoclonal Antibodies Market: Sales of Top Selling Molecules (in INR Million), 2023
Table 5 5: Drug Overview: Avastin
Table 5 6: Drug Overview: Herceptin
Table 5 7: Drug Overview: Rituxan
Table 5 8: Drug Overview: Remicade
Table 5 9: Drug Overview: Humira
Table 5 10: Drug Overview: Reditux
Table 5 11: Companies Developing Herceptin (Trastuzumab) Biosimilars
Table 5 12: Companies Developing Remicade (Infliximab) Biosimilars
Table 5 13: Companies Developing Mabthera (Rituximab) Biosimilars
Table 5 14: Companies Developing Humira (Trastuzumab) Biosimilars
Table 5 15: Companies Developing Other Monoclonal Antibody Biosimilars